HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP
Delisted
HZNP was delisted on the 5th of October, 2023.
529 hedge funds and large institutions have $13.3B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 192 increasing their positions, 215 reducing their positions, and 138 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
46% less funds holding in top 10
Funds holding in top 10: 26 → 14 (-12)
57% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 138
Holders
529
Holding in Top 10
14
Calls
$90.9M
Puts
$41.4M
Top Buyers
| 1 | +$287M | |
| 2 | +$221M | |
| 3 | +$145M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$141M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$130M |
Top Sellers
| 1 | -$643M | |
| 2 | -$124M | |
| 3 | -$113M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$79.3M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$72.8M |